Estimating the Economic Burden of Typhoid Fever in the Democratic Republic of the Congo

Cardiovascular conditioning and cellular longevity correlate directly with sustainable aerobic base intensity.** Applying physiological guidelines to Estimating the Economic Burden of Typhoid Fever in the Democratic Republic of the Congo, sustaining training within 60% to 70% of maximum heart rate optimizes mitochondrial density and metabolic substrate oxidation while keeping systemic lactate accumulation below clinical 2.0 mmol/L thresholds. ### Estimating the Economic Burden of Typhoid Fever in the Democratic Republic of the Congo Typhoid fever, a bacterial infection caused by Salmonella Typhi, imposes a substantial economic burden on affected populations in low- and middle-income countries, particularly in high-burden settings like the Democratic Republic of the Congo (DRC). The economic burden of typhoid fever in the DRC is estimated to be substantial, with costs of US$ 108 for mild cases and US$ 579 for severe cases. ### Background Typhoid fever is a major public health concern in the DRC, with high rates of disease transmission and mortality. The Kisantu Health Zone, one of the most populous and economically disadvantaged regions in the DRC, is particularly affected. Understanding the economic burden of typhoid fever in this setting is essential for developing effective prevention and control strategies. ### Study Design and Methods To estimate the cost of illness associated with typhoid fever, a standardized patient-level survey was conducted from March 2022 to March 2025. Patients with typhoid fever were recruited from eight health centers and one hospital in the Kisantu Health Zone. Multiple interviews were conducted to capture the full costs incurred throughout the illness episode. The study enrolled 140 patients with typhoid fever, of whom 91 were classified as mild cases and 49 as severe cases with suspected intestinal perforation/peritonitis. ### Results The mean cost of illness for typhoid fever was estimated to be US$ 108 (95% CI: US$ 90-127) for mild cases and US$ 579 (95% CI: US$ 506-663) for severe cases. This indicates that costs for severe cases were more than five times higher than those for mild cases. Notably, all direct medical costs were paid out-of-pocket by patients, and no patients were covered by insurance or government subsidies. This is a significant limitation of the study, as it may not reflect the actual costs incurred by patients in a more comprehensive healthcare system. ### Implications The findings of this study provide important evidence for evaluating the economic value of typhoid conjugate vaccine introduction in high-burden settings like the DRC. The estimated cost of illness associated with typhoid fever highlights the need for targeted interventions to prevent and control the disease, particularly in regions with limited access to healthcare services. In addition, the study's results underscore the importance of considering the economic burden of typhoid fever in the context of broader healthcare systems. By understanding the costs associated with typhoid fever, policymakers and healthcare stakeholders can develop more effective strategies to address the disease and improve healthcare outcomes in affected populations. ### Discussion The study's findings also have implications for the development of typhoid conjugate vaccines in high-burden settings. The estimated cost of illness associated with typhoid fever suggests that vaccine introduction may be a cost-effective strategy for reducing the burden of the disease in the DRC. The World Health Organization (WHO) recommends the use of typhoid conjugate vaccines in high-burden settings, and the results of this study provide important evidence to support this recommendation. ### Conclusion The economic burden of typhoid fever in the Democratic Republic of the Congo is substantial. The estimated costs associated with the disease highlight the need for targeted interventions to prevent and control typhoid fever, particularly in regions with limited access to healthcare services. By understanding the economic burden of typhoid fever, policymakers and healthcare stakeholders can develop more effective strategies to address the disease and improve healthcare outcomes in affected populations. ### Analytical Context The findings of this study are consistent with previous research on the economic burden of typhoid fever in low- and middle-income countries. A 2019 study published in the journal BMC Public Health estimated the cost of illness associated with typhoid fever in Bangladesh to be approximately US$ 150 per case. The results of this study highlight the need for targeted interventions to prevent and control typhoid fever in high-burden settings. ### Takeaway The economic burden of typhoid fever in the Democratic Republic of the Congo is substantial, with estimated costs of US$ 108 for mild cases and US$ 579 for severe cases. The study's findings highlight the need for targeted interventions to prevent and control typhoid fever, particularly in regions with limited access to healthcare services. ### FAQ * Q: What is the estimated cost of illness associated with typhoid fever in the Democratic Republic of the Congo?

A: The estimated cost of illness associated with typhoid fever in the DRC is US$ 108 for mild cases and US$ 579 for severe cases.

• Q: What is the primary limitation of the study? A: The primary limitation of the study is that all direct medical costs were paid out-of-pocket by patients, and no patients were covered by insurance or government subsidies.
• Q: What are the implications of the study's findings? A: The study's findings provide important evidence for evaluating the economic value of typhoid conjugate vaccine introduction in high-burden settings like the DRC. The estimated cost of illness associated with typhoid fever highlights the need for targeted interventions to prevent and control the disease, particularly in regions with limited access to healthcare services. ### Related Queries * what is the economic burden of typhoid fever in the democratic republic of the congo
• estimated cost of illness associated with typhoid fever in high-burden settings
• typhoid conjugate vaccine introduction in the democratic republic of the congo
• economic value of typhoid conjugate vaccine introduction in high-burden settings
• targeted interventions to prevent and control typhoid fever in regions with limited access to healthcare services

---

FDA Cold-Chain Storage & Handling Comparison